Optiver Holding’s Applied Therapeutics APLT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-427
Closed -$43 2322
2025
Q4
$43 Buy
+427
New +$271 ﹤0.01% 2396

Optiver Holding's APLT Position: Q1 2026 in Review

Optiver Holding sold out of Applied Therapeutics (APLT) in Q1 2026, closing a stake of 427 shares — an estimated $43 sold.

Optiver Holding first reported a position in APLT in Q4 2025 and held it in 1 quarter. The position peaked at $43 in Q4 2025. 0 funds tracked by Wall St. Rank hold APLT as of Q1 2026.

  • Optiver Holding reported no remaining Applied Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Optiver Holding sold 427 Applied Therapeutics shares in Q1 2026, an estimated $43.
  • Optiver Holding first reported a position in Applied Therapeutics in Q4 2025 and held it in 1 quarter.
  • Optiver Holding's Applied Therapeutics position peaked at $43 in Q4 2025.
  • 0 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.